Browsing Featured News by Author "Ackland, J"
Now showing items 1-1 of 1
-
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.
Omosa-Manyonyi, G; Mpendo, J; Ruzagira, E; Kilembe, W.; Chomba, E; Roman, F; Bourguignon, P; Koutsoukos, M; Collard, A; Voss, G; Laufer, D; Stevens, G; Hayes, P; Clark, L; Cormier, E; Dally, L; Barin, B; Ackland, J; Syvertsen, K; Zachariah, D; Anas, K; Sayeed, E; Lombardo, A; Gilmour, J; Cox, J; Fast, P; Priddy, F (University of Nairobi, 2015)BACKGROUND: Sequential prime-boost or co-administration of HIV vaccine candidates based on an adjuvanted clade B p24, RT, Nef, p17 fusion protein (F4/AS01) plus a non-replicating adenovirus 35 expressing clade A Gag, ...